Randomised Controlled TrialtaVNS

Efficacy and safety of transcutaneous auricular vagus nerve stimulation plus pregabalin for radiotherapy-related neuropathic pain in patients with head and neck cancer (RELAX): a phase 2 randomised trial

Zuo X, Xu Y, Li S, Jiang J, Wang J, Zhu Y, Pan D, Li H, Chen Y, Chen Y, et al.

eClinicalMedicine · 2025

Key finding

Between September 16, 2022, and December 1, 2023, 116 eligible patients (mean age, 50.8 [standard deviation (SD), 8.8] years; 40 [34.5%] were women) were randomly assigned into groups.

Condition
Cancer Support
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Cite this study

Zuo, X., Xu, Y., Li, S., Jiang, J., Wang, J., Zhu, Y., Pan, D., Li, H., Chen, Y., Chen, Y., Rong, X., Zheng, D., Lu, K., Mai, H., Chen, M., Chen, P., Li, J., Simone, C. B., Chua, M. L. K., … Tang, Y. (2025). Efficacy and safety of transcutaneous auricular vagus nerve stimulation plus pregabalin for radiotherapy-related neuropathic pain in patients with head and neck cancer (RELAX): a phase 2 randomised trial. eClinicalMedicine, 86, 103345. https://doi.org/10.1016/j.eclinm.2025.103345

Related studies in Cancer Support

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.